-
Expert Outlook: Penumbra Through The Eyes Of 7 Analysts
30 Jul 2025 22:56 GMT
… unveils how financial experts perceive Penumbra. The following summary outlines key … date on Penumbra analyst ratings.
Get to Know Penumbra Better
Penumbra Inc develops … marketing of inventive medical products.
Penumbra's Financial Performance
Market …
-
Penumbra Inc (NYSE:PEN) Surpasses Q2 2025 Earnings and Revenue Estimates Amid Market Challenges
29 Jul 2025 21:05 GMT
… likely reflects continued demand for Penumbra’s thrombectomy and embolization products … play.
Analyst Expectations vs. Performance
Penumbra’s outperformance in Q2 aligns … reaction post-earnings.
Conclusion
While Penumbra’s Q2 results demonstrate solid …
-
Penumbra (PEN) Announces Completion of Enrollment in STORM-PE Clinical Trial
11 Jul 2025 12:19 GMT
… vacuum thrombectomy (CAVT) through utilising Penumbra’s Lightning Flash™ plus anticoagulation … high risk pulmonary embolism (PE). Penumbra (PEN) Announces Completion of Enrollment … the regions and productivity improvements. Penumbra, Inc. (NYSE:PEN) increased …
-
ICE’s Penumbra of Abuse
07 Jul 2025 17:46 GMT
I wanted to elaborate on some points Theda Skocpol addressed in her reader email this weekend about ICE and the supercharged ICE the new Trump budget law envisions. Some of this may be obvious just seeing what we’ve all seen in recent months. But I wanted …
-
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release And Conference Call For July 29, 2025
01 Jul 2025 22:00 GMT
… , 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced … completion of the call.
About Penumbra
Penumbra, Inc., the world's … X .
Investor Relations
Penumbra, Inc.
[email protected]
SOURCE Penumbra, Inc.
WANT YOUR …
-
Penumbra to gain market share in peripheral embolisation coils with Ruby XL system: GlobalData
23 Jun 2025 06:58 GMT
… Healthcare Facility Invoicing Database, Penumbra currently holds the majority … its current coils, Penumbra has a competitive advantage … a competitive ASP, Penumbra may displace competitor coils … procedures.
Paterson concludes, “Penumbra stands to maintain its …
-
PENUMBRA INC (NYSE:PEN) – A Strong Growth Stock with Technical Breakout Potential
21 Jun 2025 12:45 GMT
PENUMBRA INC (NYSE:PEN) was identified …
-
Penumbra may gain market share in peripheral embolisation coils with Ruby XL
21 Jun 2025 05:54 GMT
… healthcare facility invoicing database, Penumbra currently holds the majority … its current coils, Penumbra has a competitive advantage … a competitive ASP, Penumbra may displace competitor coils … for relevant procedures.
Penumbra stands to maintain its …
-
Inquis, Penumbra advance thrombectomy treatments
17 Jun 2025 21:54 GMT
… embolism, an expanded indication, while Penumbra Inc. completed enrollment in the …
-
Penumbra completes enrollment in pulmonary embolism trial
16 Jun 2025 21:30 GMT
… system. [Image courtesy of Penumbra]
Penumbra (NYSE:PEN) announced today that … Benenati, chief medical officer at Penumbra. “The trial successfully randomized patients … pulmonary thrombus. It features Penumbra’s Lightning Intelligent Aspiration technology …